We've changed the way you complete courses

In response to user feedback we have simplified the way courses can be completed.

Until now you needed to complete the topics and modules in order, from start to finish. But from today you can complete them in any order you wish.

Just visit any topic that interests you, and when you are ready mark it as completed by clicking the green 'Mark complete' button at the bottom of the page.

Once you have completed all of the topics in a module an assessment will be provided for you.

Complete all the assessments to finish the course.

Thanks, I've got it! X

The most successful window of opportunity for diabetes prevention in NOD mice is between points A and C.

Select image for larger view


Ag: antigen
APC: antigen-presenting cell
CTLA4: cytotoxic T lymphocyte antigen-4
GAD85: glutamic acid decarboxylase 85
HLA: human leukocyte antigen
IA2: islet antigen-2
IAPP: islet amyloid polypeptide
IFIH: interferon induced helicase
IFNa: interferon alpha
IFNg: interferon gamma
IGRP: islet-specific glucose-6-phosphatase catalytic subunit-related protein
IL2Ra: interleukin 2 receptor subunit alpha
LN: lymph node
MHC I: major histocompatibility complex
Preproinsulin SP: preproinsulin signal peptide
PTPN22: protein tyrosine phosphatase, non-receptor type 22
TNFa: Tumor necrosis factor-alpha
Treg: regulatory T cell
ZnT8: zinc transporter 8

When we go to humans, most of the time we do our interventions very late, when autoantibodies are already present and where the immune system is already activated and is already destroying the beta cells. And so, an important lesson that we can learn from human interventions, but also the NOD interventions is that perhaps, yes, there are some criticisms of the NOD mouse model but also, perhaps, that our timing of intervention is not appropriate.
Play the audio to learn more

van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev. 2011 Jan;91(1):79-118.